WHO Recommends Two New Ebola Vaccines for Clinical Trials Amid DRC's Bundibugyo Outbreak
The World Health Organization (WHO) has recommended the inclusion of two new Ebola vaccine candidates for clinical trials in the Democratic Republic of Congo (DRC), where the country is currently grappling with the Bundibugyo outbreak.
The Tumaini trial, a part of the recommendation, aims to evaluate multiple vaccine candidates through a ring-vaccination approach involving contacts of people confirmed to have Bundibugyo virus disease. The trial focuses on protecting potential contacts from contracting the virus and spreading the outbreak further.
The Bundibugyo Ebola virus disease has caused concern in the DRC, with the recent outbreak posing significant challenges to public health efforts. The WHO's decision to recommend the two vaccines for clinical trials demonstrates the organization's commitment to combatting the outbreak and finding effective solutions.
- The Bundibugyo outbreak has caused concern in the Democratic Republic of Congo
- The Tumaini trial aims to evaluate multiple vaccine candidates for protecting potential contacts
- The WHO recommendation highlights the organization's efforts to combat the outbreak and find effective solutions
The Bundibugyo virus disease outbreak has been ongoing since November 2021, with the DRC's Ministry of Health confirming 12 cases and five deaths as of February 2022. The WHO has been actively involved in providing guidance, resources, and support to combat the outbreak.
WHO Recommends Two New Ebola Vaccines for Clinical Trials in DRC
The World Health Organization (WHO) has recommended the inclusion of two new Ebola vaccine candidates for clinical trials in the Democratic Republic of Congo (DRC), where the country is currently grappling with the Bundibugyo outbreak.
The Tumaini trial, a part of the recommendation, aims to evaluate multiple vaccine candidates through a ring-vaccination approach involving contacts of individuals confirmed to have Bundibugyo virus disease. The trial focuses on protecting potential contacts from contracting the virus and spreading the outbreak further.
The Bundibugyo virus disease outbreak has been ongoing since November 2021, with the DRC's Ministry of Health confirming 12 cases and five deaths as of February 2022. The WHO has been actively involved in providing guidance, resources, and support to combat the outbreak.
<small>Source: Premium Times Nigeria — read the original story there.</small>
